MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
shares of common stock...
$15,573,966
Proceeds from issuance of
shares of common stock...
$4,592,462
Proceeds from issuance of
shares of common stock...
$3,826,336
Proceeds from the
exercise of stock options
$34,115
Net cash provided by
financing activities
$23,724,054
Canceled cashflow
$302,825
Net change in cash
and cash...
$4,517,801
Canceled cashflow
$19,206,253
Deferred offering costs
$302,825
Stock-based compensation
expense
$6,046,661
Other assets
-$110,548
Prepaid assets and other
current assets
-$82,282
Interest accrued on
license payable
$20,250
Net cash used in
operating activities
-$19,206,253
Canceled cashflow
$6,259,741
Net loss
-$22,227,852
Other accrued
expenses
-$2,354,504
Accounts payable
-$512,536
Accrued compensation
-$300,145
Accrued interest
-$70,957
Back
Back
Cash Flow
source: myfinsight.com
ACTUATE THERAPEUTICS, INC. (ACTU)
ACTUATE THERAPEUTICS, INC. (ACTU)